Real world use of dolutegravir two drug regimens.

Conor Bowman,Alissa Ambrose,Tanmay Kanitkar, Katia Flores,Pedro Simoes,Jennifer Hart,Alan Hunter, Jane Akodu,Tristan J Barber

AIDS (London, England)（2023）

引用 3|浏览8

暂无评分

摘要

Majority of experience is in DTG/3TC stable switch. Minority of patients developed side-effects. Low number of virological failures, one developed integrase inhibitor resistance. Viral failure associated with MTR, commensurate with trial data showing no failure with resistance if DTG/3TC STR used. Overall DTG-2DR demonstrates high efficacy in real-world setting.

查看译文

关键词

dolutegravir,drug

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要